or
Bookmark and Share
Method for the determination of leukemic cells
   
Document Number
US Patent 4390518
Issued Date
June 28, 1983
Link
Inventors
Map
Abstract
A method for the detection and for the differential diagnostic determination of leukemic cells, comprises treating leucocytes with a supravital dye and evaluating the different staining of healthy and leukemic cells. Preferred dyes are triphenylmethane dyes of the phthalein and sulphophthalein classes.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
6
Comments:
no comments yet
Published
June 28, 1983
Application Number
06/254,723
Filed
April 16, 1981
US Classification
435/34  
Int'l Classification
G01N   33/50   (20060101)   G01N   33/487   (20060101)  
Attorney/Law Firm
Priority Data
Apr 16, 1980 [DE] 3014563
USPTO Field of Search
424/3.7   23/23B  
Related Patents
4615878 - Metachromatic dye sorption means for differential determination of sub-populations of lymphocytes

Differentiation, identification and enumeration of sub-populations of lymphocytes including B-cells and T-cells can now be further discriminated into their sub-populations by means of basic orange 21 as a supravital stain to provide distinctive morphologic differences between B-cells, T-suppressor cells, T-helper cells and natural killer (NK) cells without resorting to the use of individual monoclonal antibodies for differentiation of each of the above. The differentiation, identification and enumeration of the foregoing cells can be accomplished by means of both white light absorbance and fluorescence measurements, singly or in sequential combinations.

5468618 - Article for performing immunological assays utilizing organic dyes to immobilize immunologically reactive components to a solid phase support and methods for producing and utilizing same - Owned by Immucor, Inc. (Norcross, GA)

An article for performing solid-phase immunological assays and methods for performing assays utilizing such article. A solid-phase support suitable for immunological assays is stained with an organic dye that has a net-positive charge and a hydrophobic aromatic ring structure. An immunologically reactive component having a net-negative charge, such as a whole cell, is securely immobolized by the dye to the support through noncovalent interactions. A sample of biological fluid may be added to the article to which the immunologically reactive component has been immobilized to effect binding of antigens or antibodies in the sample which are specific to the immobilized component. The presence of the antigen-antibody complex may then be determined by any known means.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us